1 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
2 |
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
3 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
4 |
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.
|
|
|
|
In: Alzheimer's & dementia : the journal of the Alzheimer's Association, vol 16, iss 1 (2020)
|
|
BASE
|
|
Show details
|
|
5 |
Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
|
|
|
|
In: Alzheimers Dement (2020)
|
|
BASE
|
|
Show details
|
|
6 |
Utility of the CDR® plus NACC FTLD in Mild FTLD: Data from the ARTFL/LEFFTDS Consortium
|
|
|
|
In: Alzheimers Dement (2020)
|
|
BASE
|
|
Show details
|
|
7 |
Longitudinal structural and metabolic changes in frontotemporal dementia
|
|
|
|
In: Neurology (2020)
|
|
BASE
|
|
Show details
|
|
8 |
Data from: Longitudinal structural and metabolic changes in frontotemporal dementia ...
|
|
|
|
BASE
|
|
Show details
|
|
9 |
Patient-Tailored, Connectivity-Based Forecasts of Spreading Brain Atrophy
|
|
|
|
BASE
|
|
Show details
|
|
10 |
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.
|
|
|
|
In: Annals of clinical and translational neurology, vol 5, iss 10 (2018)
|
|
BASE
|
|
Show details
|
|
11 |
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.
|
|
|
|
In: Annals of clinical and translational neurology, vol 5, iss 10 (2018)
|
|
BASE
|
|
Show details
|
|
12 |
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.
|
|
|
|
BASE
|
|
Show details
|
|
13 |
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease.
|
|
|
|
BASE
|
|
Show details
|
|
14 |
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.
|
|
|
|
In: Brain and behavior, vol 7, iss 4 (2017)
|
|
BASE
|
|
Show details
|
|
15 |
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.
|
|
|
|
In: Brain and behavior, vol 7, iss 4 (2017)
|
|
BASE
|
|
Show details
|
|
16 |
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease
|
|
|
|
BASE
|
|
Show details
|
|
|
|